|
CN110996912A
|
|
Dry powder compositions for intranasal delivery
|
|
CN108697803A
|
|
The pharmaceutical composition of transmucosal administration
|
|
CA2700426A1
|
|
Compositions comprising lipophilic active compounds and method for their preparation
|
|
US2005226934A1
|
|
Inclusion complexes of active compounds in acrylate (co)polymers and methods for their production
|
|
US2005233003A1
|
|
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
|
US2005249786A1
|
|
Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
|
|
US2006228419A1
|
|
Solvent-free process for preparation of hydrophilic dispersions of nanoparticles of inclusion complexes
|
|
US2005227911A1
|
|
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
|
EP1670516A2
|
|
Water soluble nanoparticles inclusion complexes
|
|
US2005191359A1
|
|
Water soluble nanoparticles and method for their production
|
|
IL160957D0
|
|
Water soluble nanoparticles of hydrophilic and hydrophobic active materials
|
|
US6878693B2
|
|
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
